Evidence map›Paper›PMID 31474426›Full record

ArticleThe Journal of pediatrics2019

Sex-Dependent Gene Expression in Infants with Neonatal Opioid Withdrawal Syndrome.

Elizabeth Yen, Tomoko Kaneko-Tarui, Robin Ruthazer, Karen Harvey-Wilkes, Mona Hassaneen, Jill L Maron

Open access · greenAbstract read
In one paragraph

Article in The Journal of pediatrics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 30 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Molecular evidence of the sex-specific effects of prenatal opioid exposure.Journal of perinatology : official journal of the California Perinatal Association · 2025
    Article
  11. Article
  12. Article
  13. The Cost of Opioid Use in High-Risk Hospitalized Infants.The Journal of surgical research · 2024
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Elizabeth YenDepartment of Pediatrics, Floating Hospital for Children/Tufts University School of Medicine, Boston, MA. Electronic address: eyen@tuftsmedicalcenter.org.
Tomoko Kaneko-TaruiMother Infant Research Institute, Tufts Medical Center, Boston, MA.
Robin RuthazerBiostatistics, Epidemiology, and Research Design, Tufts Medical Center, Boston, MA.
Karen Harvey-WilkesDepartment of Pediatrics, Floating Hospital for Children/Tufts University School of Medicine, Boston, MA.
Mona HassaneenUniversity of British Columbia, Vancouver, Canada.
Jill L MaronDepartment of Pediatrics, Floating Hospital for Children/Tufts University School of Medicine, Boston, MA; Mother Infant Research Institute, Tufts Medical Center, Boston, MA.
Tufts University · USTufts Medical Center · USUniversity of British Columbia · CA

Funding

Tufts Clinical and Translational Science Institute (Pilot Supplement)UL1TR002544 · NCATS · TUFTS UNIVERSITY BOSTON · PI SELKER, HARRY P. · 2018 to 2022
$50.2M
NCATS NIH HHS UL1 TR002544
6 · The paper itself

Abstract

objectivesTo evaluate salivary biomarkers that elucidate the molecular mechanisms by which in utero opioid exposure exerts sex-specific effects on select hypothalamic and reward genes driving hyperphagia, a hallmark symptom of infants suffering from neonatal opioid withdrawal syndrome (NOWS). STUDY

designWe prospectively collected saliva from 50 newborns born at ≥34 weeks of gestational age with prenatal opioid exposure and 50 sex- and gestational age-matched infants without exposure. Saliva underwent transcriptomic analysis for 4 select genes involved in homeostatic and hedonic feeding regulation (neuropeptide Y2 receptor [NPY2R], proopiomelanocortin [POMC], leptin receptor [LEPR], dopamine type 2 receptor [DRD2]). Normalized gene expression data were stratified based on sex and correlated with feeding volume on day of life 7 and length of stay in infants with NOWS requiring pharmacotherapy.

resultsExpression of DRD2, a hedonistic/reward regulator, was significantly higher in male newborns compared with female newborns with NOWS (Δ threshold cycle 10.8 ± 3.8 vs 13.9 ± 3.7, P = .01). In NOWS requiring pharmacotherapy expression of leptin receptor, an appetite suppressor, was higher in male subjects than female subjects (Δ threshold cycle 8.4 ± 2.5 vs 12.4 ± 5.1, P = .05), DRD2 expression significantly correlated with intake volume on day of life 7 (r = 0.58, P = .02), and expression of NPY2R, an appetite regulator, negatively correlated with length of stay (r = -0.24, P = .05).

conclusionsPrenatal opioid exposure exerts sex-dependent effects on hypothalamic feeding regulatory genes with clinical correlations. Neonatal salivary gene expression analyses may predict hyperphagia, severity of withdrawal state, and length of stay in infants with NOWS.

Indexed as

Gene ExpressionAnalgesics, OpioidCase-Control StudiesFemaleGene Expression ProfilingGenetic MarkersHumansHyperphagiaInfant, NewbornMaleNeonatal Abstinence SyndromePilot ProjectsPro-OpiomelanocortinProspective StudiesReceptors, Dopamine D2Receptors, LeptinAnalgesics, OpioidDRD2 protein, humanGenetic MarkersLEPR protein, humanneuropeptide Y2 receptorPro-OpiomelanocortinReceptors, Dopamine D2Receptors, LeptinReceptors, Neuropeptide Yhyperphagiahypothalamusnewbornsopioid exposurereward signalingsalivary gene expressionsex differences

Identifiers

PMID31474426
PMCPMC10564583
OpenAlexW2970901391

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.